Myotherix
WebThe company was incorporated in 2013 and is based in Union City, California. digitGaps report on MYOTHERIX Inc delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and structures, and company operations by examining its performance in local market and global economy. digitGaps … WebMyoTherix is a clinical-stage drug discovery and development company for patients suffering from rare neuromuscular disorders. Search Crunchbase Start Free Trial
Myotherix
Did you know?
WebSep 1, 2015 · MyoTherix, Inc. is a venture-supported biotechnology company focused on developing novel therapeutics for the treatment of muscle disorders. Its lead product opportunity utilizes an innovative and novel approach to target both cardiac and skeletal muscle weakness. WebInc. Myotherix has a registered in the System for Award Management for doing business with and bidding for contracts by the United States government. Cage Code 72CN4 was listed as their unique company identifier. The company registered with SAM on 2013-12-04 and the registration with the below details. Company Details
WebApr 16, 2024 · LONDON, Silence Therapeutics plc (LON: SLN) (“Silence” or “the Company”) a leader in the discovery, development and delivery of novel RNA therapeutics for the treatment of serious diseases, is pleased to announce the appointment of Giles Campion, MD as Head of R&D and Chief Medical Officer, effective 1 June 2024. WebMyoTherix is a clinical-stage drug discovery and development company for patients suffering from rare neuromuscular disorders.
WebLooking for a credit report on Myotherix, Inc.? Our Business Information Report Snapshot is a collection of business credit scores and ratings that help you gauge the financial health … WebSep 1, 2015 · NEWPORT BEACH, Calif., September 1, 2015 – CureDuchenne Ventures LLC, a company that funds research to find a cure for Duchenne muscular dystrophy, announced …
WebCo-Founder and Executive Chairman Dr. de Souza has deep experience in creating and developing virtual biotechnology companies. He has participated as a CEO/Executive Chairman/Co-Founder of NFlection Therapeutics, Chromaderm, SeylanMed, PellePharm, MyoTherix, Lotus Tissue Repair, and others.
WebMyoTherix is a drug discovery and development company focusing on therapies for patients suffering from Charcot Marie Tooth disease, Duchenne muscular dystrophy, and other … fernando landscapingWebMyotherix, Inc. Headquarters 29540 Kohoutek Way Union City, California94587 1-857-222-4653 Driving Directions » Myotherix, Inc. Summary ABOUT Overview Myotherix focuses on developing therapies for patients suffering from Duchenne muscular dystrophy and muscle disorders. Myotherix, Inc. was founded in 2013. delhi housing societyWebSee Myotherix funding rounds, investors, investments, exits and more. Evaluate their financials based on Myotherix's post-money valuation and revenue. delhi hotels with poolsWebSep 1, 2015 · “MyoTherix’s lead research program intends to improve both cardiac and skeletal muscle function, as well as reduce inflammation and facilitate new muscle regeneration,” said John Kincaid, co-Founder of MyoTherix Inc. “We are pleased to work with the team at CureDuchenne and look forward to developing this new approach to the … fernando lamas and esther williams marriageWebMyoTherix is developing therapeutics for the treatment of Duchenne muscular dystrophy. The therapeutics are being developed to improve cardiac and skeletal Research … fernando lamas on johnny carsonWebHe also served as medical advisor to MyoTherix Inc and is a co-founder of PepGen Ltd. Dr. Campion hold bachelors and doctorate degrees in medicine from the University of Bristol and is listed on the General Medical Council (UK) Specialist Register (Rheumatology). fernando lazaro carreter wikipediaWebMyotherix is based out of Union City. The firm last filed a Form D notice of exempt offering of securities on 2024-03-01. The notice included securities offered of Equity fernando leon cetys